Virbac: share collapses after results.

(CercleFinance.com) - Virbac has made cautious forecasts.
With its share down 7%, the animal health specialist is therefore the sharpest faller in the SRD.

The group nevertheless reported net attributable profit that was up 268% compared to 2015 at 34.6 million euros.

Finally, its annual consolidated sales amounted to 871.8 million euros, up 2.3% (+4.5% like-for-like). However, management said that "2017 should see a moderate rise in the group's sales at constant exchange rates."

Regarding forecasts, the start of the year seems to show a downward trend in sales at constant currencies - so much so that growth in sales should only be limited this year, Oddo added in its report this morning.


Copyright (c) 2017 CercleFinance.com. All rights reserved.